Orphan drug sales are growing more than twice as fast as those of non-orphan pharmaceuticals. 340B health systems are generally well suited to provide the skilled healthcare that high-touch orphan ...

Incorporating systems thinking into drug value assessment promises more realistic evaluations of the impact of new therapies, but it requires buy-in from policy makers, biopharmaceutical firms, ...

September 12, 2012 — A centralized prescription network that gives real-time access to data on filled prescriptions for individual patients can reduce inappropriately filled prescriptions for opioids ...

With the ease of online publishing, the number of journals has exploded, and with them the number of papers. It has gotten ...

Synthetic drugs are rapidly reshaping global drug markets, creating new and less predictable health risks while placing growing pressure on already strained health systems. Speaking at an ...